GPSM2

Chr 1

G protein signaling modulator 2

Also known as: CMCS, DFNB82, LGN, PINS

The protein encoded by this gene belongs to a family of proteins that modulate activation of G proteins, which transduce extracellular signals received by cell surface receptors into integrated cellular responses. The N-terminal half of this protein contains 10 copies of leu-gly-asn (LGN) repeat, and the C-terminal half contains 4 GoLoco motifs, which are involved in guanine nucleotide exchange. This protein may play a role in neuroblast division and in the development of normal hearing. Mutations in this gene are associated with autosomal recessive nonsyndromic deafness (DFNB82). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.86
Clinical SummaryGPSM2
🧬
Gene-Disease Validity (ClinGen)
Chudley-McCullough syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
37 unique Pathogenic / Likely Pathogenic· 164 VUS of 353 total submissions
📖
GeneReview available — GPSM2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.86LOEUF
pLI 0.000
Z-score 2.21
OE 0.60 (0.430.86)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.26Z-score
OE missense 0.81 (0.740.90)
297 obs / 364.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.60 (0.430.86)
00.351.4
Missense OE?0.81 (0.740.90)
00.61.4
Synonymous OE?0.79
01.21.6
LoF obs/exp: 22 / 36.4Missense obs/exp: 297 / 364.4Syn Z: 1.85
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveGPSM2-related sensorineural hearing loss with corpus callosum hypoplasia, gray matter heterotopia and arachnoid cystsLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.74top 25%
GOF
0.72top 25%
LOF
0.3163th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

353 submitted variants in ClinVar

Classification Summary

Pathogenic11
Likely Pathogenic26
VUS164
Likely Benign84
Benign28
Conflicting19
11
Pathogenic
26
Likely Pathogenic
164
VUS
84
Likely Benign
28
Benign
19
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
11
0
0
0
11
Likely Pathogenic
24
1
1
0
26
VUS
2
132
26
4
164
Likely Benign
0
8
45
31
84
Benign
0
1
27
0
28
Conflicting
19
Total371429935332

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

14 pathogenic / likely-pathogenic (of 34) ClinVar copy-number / structural variants overlap GPSM2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GPSM2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →